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Introduction. Some studies report that assessing regional 123I-cardiac MIBG uptake can aid
in the diagnosis of Lewy body disease, but others report heterogeneity in healthy controls. We
aimed to evaluate regional cardiac MIBG uptake patterns in healthy older adults and patients
with dementia.
Methods. 31 older adults with normal cognition, 15 Alzheimer’s disease (AD), and 17
Dementia with Lewy bodies (DLB) patients were recruited. 5 individuals had previous
myocardial infarction. Participants with sufficient cardiac uptake for regional SPECT analysis
(29/31 controls, 15/15 AD, 5/17 DLB) had relative uptake pattern recorded. Controls were
assessed for risk of future cardiovascular events using QRISK2, a validated online tool.
Results. In controls uptake was reduced in the inferior wall (85%), apex (23%), septum
(15%), and lateral wall (8%). AD and DLB showed similar patterns to controls. Lung or liver
interference was present in 61% of cases. Myocardial infarction cases showed regional
reductions in uptake, but normal/borderline planar uptake. In controls, there was no rela-
tionship between cardiovascular risk score and uptake pattern.
Conclusions. Significant variability of regional cardiac 123I-MIBG uptake is common in
cases with normal planar cardiac uptake. Heterogeneity of regional uptake appears non-specific
and unlikely to aid in the diagnosis of Lewy body disease. (J Nucl Cardiol 2019)
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Abbreviations
DLB Dementia with Lewy bodies
AD Alzheimer’s disease
FP-CIT I-123N-x-fluoropropyl- 2b-car-
bomethoxy- 3b-(4-iodophenyl)
nortropane
MIBG I-123 metaiodobenzylguanidine
SPECT Single photon emission computed
tomography
HMR Heart-to-mediastinum ratio
MI Myocardial infarction
AF Atrial fibrillation
CAD Coronary artery disease
ECG Electrocardiogram
BACKGROUND
Dementia with Lewy bodies (DLB) is the second
most common form of neurodegenerative dementia after
Alzheimer’s disease, accounting for 5-10% of cases.1,2
Accurate diagnosis is important for clinical manage-
ment, prognosis, and carer wellbeing,3–5 but initial
misdiagnosis outside the specialist setting is com-
mon.2,6,7 Cardiac 123I-metaiodobenzylguanidine
sympathetic innervation imaging (‘‘cardiac MIBG’’) is
an established technique for differentiating DLB from
other dementias. Sympathetic denervation occurs in
DLB, resulting in low cardiac MIBG uptake on the scan,
whereas healthy controls and patients with other demen-
tias such as Alzheimer’s disease have normal uptake.8–14
The technique has been used in Japan in Lewy body
disease for over a decade and was recently included as
an indicative biomarker in the fourth DLB consensus
criteria, alongside 123I-FP-CIT SPECT.6
Cardiac MIBG studies are typically quantified on
planar images using the heart-to-mediastinum ratio
(HMR) as a diagnostic indicator, where HMR is the
ratio between the count density in a cardiac left
ventricular region (mean pixel value) and the count
density in a mediastinal region of non-specific uptake.
Abnormal scans have reduced cardiac uptake as indi-
cated by a low HMR. The HMR is an assessment of the
overall cardiac uptake and does not take regional
differences in uptake throughout the left ventricle into
account. Regional variation of uptake can be assessed
using SPECT imaging.
Published studies exploring the use of SPECT
cardiac MIBG imaging for diagnosing Lewy body
disease have suggested that regional assessment of
cardiac uptake could improve sensitivity as regional
defects may occur before global loss is apparent.13,15–19
However, we have noted that regional count reductions
are sometimes seen in probable AD subjects who have
normal planar scan appearances, suggesting that discrete
areas of reduced regional counts may be non-specific,
e.g., due to unreported silent myocardial infarction, or
artifactual, e.g., due to attenuation or the influence of
extra-cardiac activity. It has been reported in the
literature that heterogeneous cardiac MIBG count dis-
tribution can occur in healthy controls, with relative
reduction most commonly seen in the inferior wall.19–26
This may be due to true physiological variation in
sympathetic nerve distribution or artifacts caused by the
imaging process—either from the signal being attenu-
ated by the body or by interference from non-cardiac
activity, predominantly the liver.27–29 Although several
groups investigating the diagnostic accuracy of cardiac
123I-MIBG for the diagnosis of Lewy body disease have
acquired SPECT data alongside planar, often it is only
the planar scans that have been used for analysis with
the SPECT results not reported,12,30–33 suggesting that
the added value of SPECT is unclear. In their 2015
multicentre study, Yoshita et al used SPECT for visual
analysis but it was not clear on what basis the SPECT
images were deemed normal or abnormal.10
We recruited volunteers over 60 years of age,
healthy controls, DLB patients, and Alzheimer’s disease
patients, and performed cardiac MIBG SPECT imaging
to gain a better understanding of cardiac MIBG distri-
bution in these groups and therefore how to interpret
patient scans. Our objective was to compare the distri-
bution pattern of MIBG in the heart seen in these clinical
groups. The underlying hope was that we may be able to
distinguish confounding regional reductions in cardiac
uptake due to cardiac disease from pathological ones
due to Lewy body disease by looking at heterogeneity,
thereby improving specificity. Sensitivity may also be
improved if we were to find any characteristic patterns
of reduction associated with Lewy body disease.
METHODS
Participants
Older people without cognitive impair-
ment (controls) Thirty-one healthy adults aged over
60 years were recruited as part of an ongoing study into
cardiac MIBG in a representative UK population of older
adults. They underwent a detailed neurological and cognitive
examination by a research physician. All had had normal
cognition, no parkinsonism, and had a normal MRI brain
scans. No subjects had Class II or worse heart failure according
to the New York Heart Association classification,34 or had had
a myocardial infarction in the previous year or were taking
tramadol, labetalol or tricyclic antidepressants. Previous car-
diac history, such as myocardial infarction (MI) more than
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12 months prior to recruitment or atrial fibrillation was
recorded as part of medical history taking. Subjects were not
excluded if they had risk factors for cardiac disease, such as a
history of smoking, raised blood pressure, or Type 2 diabetes
because we aimed to recruit typical older adults with normal
cognition. In our clinical studies in DLB we aim to assess
cardiac MIBG in a ‘‘real-world’’ setting, where risk factors for
cardiac disease are extremely common. However, a detailed
medical history was taken, which later enabled an estimate of
cardiac risk to be made using the QRISK2 tool, recommended
by NICE in Clinical Guideline 181 Cardiovascular disease:
risk assessment and reduction.35 QRISK2 uses the ratio of total
cholesterol to high density lipoproteins as a risk factor, with a
ratio of 4 used as default. These parameters were not part of
our original study design so were not available for most of the
volunteers. As the true ratios were not known, a ratio of 6,
which is regarded as the upper limit by Heart UK, was input
for those with high cholesterol disclosed in their medical
history and the default of 4 used for everyone else. Two
subjects had documented heart disease, making the QRISK2
score inappropriate—their risk scores were still calculated with
this recorded as a limitation. QRISK2 scores in controls were
assessed for any correlation with cardiac uptake using linear
regression.
Older people with dementia Seventeen patients
meeting the clinical criteria for probable dementia with Lewy
bodies and 15 meeting criteria for dementia due to Alzheimer’s
disease were recruited from memory clinics, as described in
our previous publications.36,37 Briefly, patients had their
dementia diagnoses confirmed by an expert panel of old-age
psychiatrists. They were categorized as having probable DLB
if two or more of the core consensus criteria for DLB 6
(fluctuations, visual hallucinations, REM sleep behavior dis-
order and parkinsonism) were present, and AD if none of these
were present. The same broad general inclusion criteria as
discussed above for the controls were applied to ensure the
patients were typical of the local population. Cardiac risk was
not calculated for the dementia patients since their cardiac
uptake was expected to be affected by Lewy body disease in
many cases. However cardiac history was recorded to enable
comparison with SPECT imaging results. We have previously
showed no convincing evidence of lower cardiac MIBG uptake
in patients with a previous MI, although this was a small
subset.36
Image Acquisition
All participants were administered 111 ± 10% MBq I-
123-MIBG via slow intravenous injection. Potassium iodate
tablets (170 mg) were given before and after injection to
minimize uptake of free iodine by the thyroid. Images were
acquired on a dual headed Siemens Symbia Intevo or Siemens
Symbia T series gamma camera (Siemens Healthcare, Munich,
Germany) with medium energy low penetration (MELP)
collimators. Ten minute anterior planar images were acquired
at 4 h (± 30 min) after injection. SPECT imaging was carried
out immediately after the planar image with the subject in the
supine position with arms raised if possible; however the
majority of controls (19/31) and patients (7/15 AD; 13/17
DLB) were scanned with their arms by their sides. Due to
patient comfort it was not possible to complete SPECT
imaging, even with arms down, for two of the 17 DLB patients,
both of whom had low uptake on planar imaging. For planar
imaging the energy window was 159 keV ± 10%, matrix size
was 128 9 128 and no zoom was applied. SPECT images were
acquired in H mode over 360 degrees with 120 projections of
20 s using a non-circular autocontoured orbit. The energy
window was 159 keV ± 7.5%, matrix size 64 9 64, and zoom
1.64.
Image Processing
All images were processed on a Hermes workstation
(Hermes Medical Ltd, Stockholm). Delayed anterior planar
images were analyzed to obtain the heart-to-mediastinum ratio
(HMR) using a 6 cm circular ROI placed over the left ventricle
and 4 9 3 cm rectangular ROI between the lungs in the
mediastinum as described in our previous publication.37
SPECT images were processed in Hermes Hybrid recon using
filtered back projection with a Butterworth filter of 0.38 cycles
per cm cut-off and order 8 applied. The images were reoriented
during reconstruction to align with the horizontal and vertical
long axes of the myocardium, as is standard for myocardial
perfusion SPECT, with as much extra-cardiac activity (e.g.,
liver and lung) masked out as possible.
Image Assessment
Quantitative perfusion SPECT (QPS) software (Hermes
Medical Ltd, Stockholm) was used to display the short axis,
vertical long axis, and horizontal long axis slice images in rows
for visual assessment of relative uptake. Polar plots of relative
uptake pattern were also reviewed. These plots display the
average relative uptake in the apex, anterior, lateral, inferior,
and septal walls as a percentage of the maximum pixel value.
The images and polar plots were reviewed blinded to the
clinical groupings by a Consultant Clinical Scientist experi-
enced in using the software for myocardial perfusion imaging
(EJ). The overall degree of uniformity and the relative uptake
for each of the left ventricle walls (anterior, inferior, septal,
lateral, and the apex) was recorded using the categories given
in Table 1. The ratings categories were developed by GR, EJ
and JJL by reviewing cardiac MIBG images not included in the
current study.
RESULTS
Controls with Normal Cognition
Of the 31 controls recruited, 2 had to be excluded
due to their image appearances (see below). The
remaining 29 people included were aged between 62
and 94 years (mean 75.2). Most were male (22/29) and
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white (28/29). Body mass indices (BMI) ranged from 22
to 38 kg/m2, with the mean value of 27.2 in the
overweight category. These demographics are summa-
rized in the controls and dementia patients are taken
from concurrent clinical studies, so not all the same
information was collected for dementia patients.
Table 2 alongside incidence of cardiovascular risk
factors such as smoking. The controls and dementia
patients are taken from concurrent clinical studies, so
not all the same information was collected for dementia
patients.
Table 2. Demographics summary for the controls and patients with DLB and AD included in the study
Controls DLB AD
Age
Mean ± SD 75.2 ± 8.3 77.5 ± 8.0 76.2 ± 6.8
Range 62 to 94 years 60 to 89 years 62 to 85 years
Sex 7 female (24%) 2 female (12%) 4 female (27%)
22 male (76%) 15 male (88%) 11 male (73%)
BMI (kg/m2)
Mean ± SD 27.8 ± 4.2 Not measured Not measured
Range 21.6 to 37.8
Ethnicity 28 white (97%) Not recorded Not recorded
1 Asian (3%)
Smoking 13 never smoked (45%) Not measured Not measured
13 ex-smokers (45%)
2 current smokers (7%)
1 not recorded (3%)
Diabetes 0 Type I (0%) Not recorded Not recorded
3 Type II (10%)
Systolic blood pressure
Mean ± SD 140.5 ± 17.8 Not recorded Not recorded
Range 112 to 173
On blood pressure medication 8 (28%) 4 (24%) 5 (33%)
Hypercholesterinaemia documented 11 (34%) Not recorded Not recorded
Documented cardiac history Previous MI and AF: 1 (3%) Previous MI: 2 (12%) Previous MI: 3 (20%)
Angina: 1 (3%)
ECG changes: 1 (3%)
Table 1. Rating categories for overall assessment of uptake pattern in the left ventricle and of uptake
in each of the ventricular wall regions
Overall rating categories
Uptake categories for each
wall Interference categories
Not possible to score due to
interference
Definitely uniform
Very slight heterogeneity
Patchy
Clear defect
Multiple clear defects
Other - see comment
Normal
Mildly reduced/patchy
Moderately reduced
Severely reduced
No uptake
No significant interference
Liver interference
Lung interference
Both liver and lung
interference
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Ten-year cardiac risk scores assessed with QRISK2
showed the group to be at high risk, as expected for
older adults (Figure 1). Most subjects were at higher risk
than expected for age due to the inclusion of one or more
cardiac risk factors in the calculation. However, despite
slight downward trends, there was no significant corre-
lation between cardiac risk and either overall cardiac
MIBG uptake as given by planar HMR (P = .64) or
minimum percentage relative uptake on SPECT
(P = .08) (Figure 1).
Two controls had abnormally low uptake on planar
imaging (below the normal threshold of 2.2 suggested
for medium energy collimators by the Japanese normal
database of controls20) and no discernible uptake on
SPECT imaging. These individuals had no significant
medical history and were not taking any medications
suspected of interfering with cardiac MIBG uptake,
including those without strong clinical evidence of an
effect.38 It is well recognized that occult Lewy body
disease (usually termed incidental Lewy body disease) is
present in many older people,39 which may explain the
findings in controls.
Of the remaining 29 controls, the mean planar HMR
was 2.78 and standard deviation 0.46. The SPECT
images for three of the controls were not possible to
assess due to a high degree of lung interference. A
further two with significant lung interference and two
with liver interference were assessed but may be
unreliable. Overall, 62% of the controls had some
degree of interference; lung interference in 11/29 cases
(38%) and liver interference in 7/29 (24%). Almost all
controls assessed (25/26) displayed at least one area of
clearly reduced relative uptake, most often in the
inferior wall, which was rated as normal or mildly
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Figure 1. Top: Plot of cardiac risk for our control subjects against subject age for males (blue data
points) and females (orange data points. The two males with previous cardiac history are shown in
open circles. The solid lines correspond to the mean QRISK2 database scores for white males and
females with no cardiac risk factors. The database is only available up to 84 years. Bottom: Plots of
HMR and minimum relative uptake against cardiac risk. Controls with previous cardiac history are
shown in open circles.
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reduced in only 4/26 cases (15%). Some example
images and ratings categories are shown in Figure 2.
The results are summarized in Table 3 alongside those
of the dementia patients.
People with Dementia
Of the 15 people with DLB who completed both
planar and SPECT imaging, the mean planar HMR was
“Very slight heterogeneity” 
“mulple clear defects”
“mulple clear defects”
Figure 2. Top: QPS slice data and polar plot for the single control rated as within normal limits,
showing almost perfectly uniform MIBG distribution, similar to that seen in normal Tc-99 m
myocardial perfusion images. Middle: Slice data and polar plot for a more typical control, with
reduced relative MIBG uptake inferiorly and at the apex. Bottom: A very abnormal control but
without prior known cardiac events. The sites of reduced relative uptake are shown with white
arrows.
Table 3. Frequency of regions showing reduced relative uptake for control, AD, and DLB groups
Apex Anterior wall Lateral wall Inferior wall Septal wall
Controls 6/26 (23%) 0 2/26 (8%) 22/26 (85%) 4/26 (15%)
AD 5/15 (33%) 0 2/15 (13%) 13/14 (93%) 4/15 (27%)
DLB 1/5 (20%) 0 0 4/5 (80%) 1/5 (20%)
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1.74 ± 0.83, with 10 scans resulting in HMR values
below 2.2. One DLB participant with low planar HMR
had visible cardiac uptake on SPECT images, but it was
too unclear for a meaningful SPECT reconstruction to
be obtained. Figure 3 shows example planar images for
DLB patients with normal and abnormal cardiac uptake
on planar imaging, alongside an example control image.
All five of the DLB subjects with normal planar cardiac
uptake had uptake visible on SPECT, i.e., the normal
HMRs were not caused by overlapping liver or lung.
There were therefore only five DLB SPECT scans
included for SPECT regional analysis, those with
normal planar imaging. Of the 15 people with AD,
three had HMR values below 2.2 (mean HMR
2.51 ± 0.36); however, all 15 AD patients had sufficient
cardiac uptake to reconstruct clear SPECT images.
The pattern of SPECT uptake was variable but
overall similar to that seen in the controls for both AD
and DLB (Tables 3, 4).
Effect of Myocardial Infarction on Planar
and SPECT Images
One control, three of the AD patients and two of the
DLB patients had had a previous MI. Their images are
displayed in Figure 4. The control had a borderline
HMR of 2.19 (assuming a normal range[ 2.2) despite a
large area of apparently reduced uptake at the apex and
inferiorly (lung interference anteriorly means this should
be interpreted with caution). Of the AD MI cases, one
had a borderline HMR of 2.16 and two had normal
uptake. Of the DLB MI cases, one had normal HMR
(2.85) and one had no visible cardiac uptake and so was
one of the cases excluded from SPECT regional
analysis.
The cases with previous MI showed defects of
varying magnitude and extent on SPECT and variable
planar HMRs, none of which were abnormally low. The
number of cases is too low to establish a correlation
Control with normal planar 
uptake (HMR = 2.97
DLB with normal planar uptake
(HMR = 3.53)
DLB with abnormal planar 
uptake (HMR = 1.06)
Figure 3. Example planar images of a control, a DLB patient with normal uptake on planar
imaging, and a DLB patient with typical lack of cardiac uptake on planar imaging.
Table 4. Frequency of each overall rating category for control, AD, and probable DLB groups
Control (n = 29) AD (n = 15) DLB (n = 5)
Interference present? 18 (62%) 10 (67%) 2 (40%)
Not possible to score due to interference 7 (24%) 3 (20%) 1 (20%)
Definitely uniform 0 0 0
Very mild heterogeneity 1 (3%) 0 0
Patchy 0 1 (7%) 0
Clear defect 8 (28%) 3 (20%) 2 (40%)
Multiple clear defects 13 (45%) 8 (53%) 2 (40%)
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Figure 4. Slice data and polar plots for cases with previous MI, with corresponding planar HMRs.
The sites of interference (top image) and relative reduced uptake are shown with arrows.
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between the extent of regional denervation and effect on
global HMR but it seems likely that regional denerva-
tion would have to be widespread for planar HMR to be
abnormally low.
DISCUSSION
The majority of the controls (25/26) and all the AD
patients showed at least one region of reduced relative
cardiac MIBG uptake, with 45% of controls and 53% of
AD patients showing relative reduction in multiple
regions. This suggests that the presence of areas of
reduced uptake on SPECT should not be used to
diagnose Lewy body disease, as some authors have
suggested, as this is likely to be highly non-specific. Our
controls were almost all at high risk of coronary events
over the next 10 years, so cardiac disease as a cause for
the relative reduction cannot be entirely excluded.
However, we note the lack of correlation between
QRISK2 score and non-uniformity index suggesting the
most at risk individuals are not at significantly greater
risk of cardiac sympathetic denervation.
None of the control or dementia cases demonstrated
reduced relative uptake in the anterior wall, which at
first glance suggests that this region could be a useful
target area in which to assess uptake in cases where the
planar HMR is suspected of being affected by regional
defects. However, 11 of the 29 control SPECT images
were difficult to assess due to lung interference, three of
whom were impossible to rate, making the anterior wall
uptake unreliable.
The strengths of this study include the inclusion of
older people thoroughly assessed to have normal cog-
nition but who also had other morbidities associated
with aging, including cardiac risk factors, making them
a representative sample of older adults. The patients
with dementia had an expert panel diagnostic review by
three old-age psychiatrists, a method which has been
validated against autopsy diagnosis and supported by
regulatory authorities as a ‘gold standard’.40,41 However,
a limitation is the use of only one rater for the SPECT
uniformity assessments. This does however reflect
clinical practice in radionuclide image reporting and
the results are convincing even with a single rater. A
further limitation is the lack of detailed cardiac assess-
ment and no myocardial perfusion imaging for
correlation with cardiac MIBG. However, Simula et al
have shown that myocardial perfusion imaging does not
correlate with cardiac MIBG SPECT in asymptomatic
high coronary risk cases with mild coronary artery
stenosis.42 They found a link between reduced uptake on
cardiac MIBG SPECT and degree of stenosis for the left
anterior descending artery (but not the left circumflex or
right coronary artery) and suggest that CAD could be the
cause of regional inhomogeneities on cardiac MIBG
SPECT previously reported as normal variants.42 How-
ever, on our SPECT scans the areas showing reduced
uptake are the inferior wall and/or apex for the majority
of controls (21/26), which is against cardiac disease
being the main cause as this would be expected to affect
any of the cardiac territories. The pattern that we see
suggests that either attenuation and scatter are causing
this artifact, artifacts have been introduced in acquisition
or reconstruction (e.g., due to high liver uptake), or there
is a physiological reason for the apex and inferior wall to
have reduced uptake.
The literature on regional sympathetic innervation
in healthy controls is quite mixed. Most studies report a
heterogeneous distribution within the left ventricle,
although they do not agree on the sites of reduced
uptake, perhaps related to small sample sizes and
different age groups. Early work by Sisson and col-
leagues in the 1980s on 20 men aged 20-62 years
showed a relative reduction at the apex only.43 The
European guidelines on 123I-MIBG cardiac sympathetic
imaging note that ‘‘normal cardiac MIBG distribution
includes a relatively low uptake in the inferior wall,
which is more pronounced in the elderly’’ referencing
the 1993 study of Gill et al27 in seven young adults
(29.4 ± 7.5 years) and eight middle aged, not elderly,
adults (53 ± 5.1 years). As well as the inferior reduction
Gill et al also reported septal reduction, with no
difference between apex and base.27 Tsuchimochi et al
studied 18 men and 11 women without cardiac diseases
aged between 21 and 79 years (mean 42 ± 17 years) and
reported that the inferior uptake of MIBG decreased
with age in healthy controls, especially in men.19 This is
important in the context of our study, as all participants
were over 60 years of age and most of our controls were
men. Image quality was however quite limited compared
to modern gamma camera images for both this study
published in 1995 and those of Sisson43 and Gill.27
Our results are similar to those of a more recent
study published by Asghar et al in 201725 who reported
reduced inferior wall uptake in all 14 healthy controls
studied, and suggested that these effects are not
predominantly caused by imaging artifacts. However,
all our control cases had normal anterior wall uptake,
which was not the case in the Asghar study. Interest-
ingly, in their 2012 11C Hydroxyephedrine PET study,
Wong et al showed that the lateral wall not the inferior
wall shows reduced regional innervation in healthy
controls, with relative sparing of anterior and septal
walls.44
Post-mortem tissue studies e.g.,45,46 report non-
uniform distribution of cardiac innervation, for example
in the sinus node; but do not describe the relative
distribution in the left ventricle so cannot be correlated
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with MIBG tracer uptake. However, in their post-
mortem study on the distribution of autonomic nerves in
the human heart, Kawano et al showed a small but
statistically significant reduction in the sympathetic
innervation of the inferior wall of the left ventricle
compared to the anterior wall.47 The reduction is only
around 20%, making this unlikely to explain the
substantial differences seen in 123I-MIBG uptake
between the anterior and inferior wall in many controls.
It has been hypothesized that due to its tracer
kinetics, 123I-MIBG imaging is insensitive to substantial
nerve losses in cardiac regions with mild to moderate
levels of cardiac denervation and that regional nerve
losses need to be relatively severe before a reduction in
uptake becomes apparent.48 If this is the case it makes
the modest physiological differences seen by Kawano
et al.47 even less likely to explain the cardiac MIBG
findings. We note that 11C Hydroxyephedrine (HED) has
similar kinetics to 123I-MIBG, so this doesn’t explain the
difference in relative uptake patterns.
This leaves artifacts as a possible contributor to the
apparent regional reductions in cardiac MIBG uptake. In
a study using an anthropomorphic chest phantom with
uniform myocardium activity, the count density within
the myocardium was inhomogeneous with both medium
and low energy collimators.28 There was an overesti-
mation of the measured count density in both the
anterior and the septal wall and an underestimation of
count density in the inferior wall,28 which is in line with
typical control studies and which the authors assumed
was due to attenuation. However, Gill considered
attenuation artifacts an unlikely cause of the reduced
inferior uptake in their control series, as myocardial
perfusion imaging with thallium-201 did not show
corresponding reductions.27 We note that although we
commonly see mildly reduced relative uptake in the
inferior wall on clinical myocardial perfusion images
obtained with 99mTc-tetrafosmin, these reductions are
typically less obvious than those seen on the majority of
our control 123I-MIBG images. However, both 99mTc
and 201Tl have different physical properties 123I, partic-
ularly in terms of high energy emissions and may not
give the same apparent cardiac uptake patterns. This
discrepancy could be potentially be resolved with the
use of SPECT-CT imaging to correct for attenuation and
scatter of the gamma rays from the MIBG tracer within
the body. A recent phantom study by Shibutani et al
demonstrated an inferior artifact in a myocardium insert
(scanned with a low-medium energy general purpose
collimator), which resolved with Siemens Flash3D
SPECT-CT reconstruction with ACSC.49
Regarding our single control regarded as having
uniform relative uptake, the following observations are
of note. The planar HMR was 2.69, which is a typical
value in line with the other controls (mean HMR
2.78 ± 0.46), rather than an outlier. Similarly, the BMI
of this individual was unremarkable at 28.6 (mean
27.8 ± 4.2). However, the relative uptake of the heart is
similar to that of the liver, whereas in most of the
controls the uptake is much higher in the liver than the
heart (Figure 5). In addition, the positioning of the dome
of the liver is just inferior to the heart, which is not the
case in many of the other controls. This suggests that
high liver uptake may be contributing to the apparent
reduced inferior wall uptake seen in most of the controls.
One of the few studies to directly compare 11C
Hydroxyephedrine PET with 123I-MIBG SPECT, in
patients with heart failure and coronary heart disease,
reported lower liver uptake on 11C Hydroxyephedrine
PET than 123I-MIBG SPECT, with increased uptake in
the inferior and septal regions,50 so this may explain the
difference in relative distribution reported with the two
tracers. A study comparing both tracers in ten healthy
young men with normal BMI showed lower relative
uptake in the inferior wall and septum with 123I-MIBG
SPECT compared with 11C-HED.51 This further sug-
gests that liver uptake may be responsible for the
inferior reduction, but we note that attenuation and
Figure 5. Left: coronal MIBG slice for the control subject with uniform relative cardiac uptake.
Right: a more typical control with high liver uptake relative to the heart. Images are displayed
scaled to the maximum voxel.
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scatter correction was used for the PET imaging but not
the SPECT. To our knowledge, no other studies of 123I-
MIBG and 11C-HED have been carried out in the same
cohort of healthy controls and no studies at all with CT
attenuation and scatter correction for 123I-MIBG. Fur-
ther research in this area would help to clarify the
reasons for the different pattern seen between SPECT
and PET.
Limitations
As discussed above, a limitation of this study is the
lack of definitive information on cardiac disease status
of the participants. The QRISK2 score gives an idea of
the likelihood of future events, but it is impossible to
exclude undiagnosed asymptomatic CAD. The patients
and controls were recruited to a dementia research study
for which detailed cardiac assessment was not part of the
study protocol; however an ECG and autonomic dys-
function tests were carried out. A further limitation of
this study is the lack of data from younger subjects as
only those over 60 years of age were recruited. SPECT-
CT data for attenuation and scatter correction were not
available for the patients so could not be assessed as part
of this analysis.
The administered activity of 111 MBq is lower than
reported in some cardiac MIBG studies, with 370 MBq
typically used in the US. However, 111 MBq is used in
Japan, where the majority of cardiac MIBG imaging
studies for dementia diagnosis have been performed.
Although the lower activity could give rise to slightly
noisier images, it would not explain the clear defects in
uptake seen in this study.
Due to the majority of DLB patients having
severely reduced cardiac MIBG uptake, it was only
possible to study relative uptake in a small group of five
subjects with normal planar uptake. However, this group
showed similar non-uniform SPECT uptake to the larger
control and AD groups. Our results in the AD and
control groups suggest that the presence of regional
defects in uptake cannot be a specific marker of Lewy
body disease. This is the case regardless of the number
of DLB cases included.
NEW KNOWLEDGE GAINED
Areas of relatively reduced cardiac 123I-MIBG
uptake on SPECT images are common, but not ubiqui-
tous, in cognitively normal older adults and patients with
dementia who have normal planar cardiac uptake.
Uptake is often reduced in the inferior wall and
sometimes in the septal wall, lateral wall, and apex.
Anterior wall uptake is often influenced by lung inter-
ference so appears unsuitable as a target region for
uptake assessment, at least on images uncorrected for
scatter and attenuation.
CONCLUSION
Reduced regional cardiac MIBG uptake in the
inferior wall of the left ventricle is common in older
adults and most likely related to attenuation or liver
uptake. Reductions in other areas may also be artifactual
or may be caused by mild underlying coronary artery
disease. The pattern of reduction is in any case non-
specific and therefore unlikely to aid in the diagnosis of
Lewy body disease in typical clinical settings.
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